相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Development and function of the midbrain dopamine system: what we know and what we need to
G. B. Bissonette et al.
GENES BRAIN AND BEHAVIOR (2016)
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky et al.
AUTOPHAGY (2016)
Inflammatory and Cell Death Pathways in Brain and Peripheral Blood in Parkinson's Disease
Beatrice Macchi et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons
Consiglia Pacelli et al.
CURRENT BIOLOGY (2015)
shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model
Alevtina D. Zharikov et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats
Jang-Won Lee et al.
NEUROBIOLOGY OF AGING (2015)
A Glaucoma-Associated Variant of Optineurin, M98K, Activates Tbk1 to Enhance Autophagosome Formation and Retinal Cell Death Dependent on Ser177 Phosphorylation of Optineurin
Kapil Sirohi et al.
PLOS ONE (2015)
The Interplay between Alpha-Synuclein Clearance and Spreading
Tomas Lopes da Fonseca et al.
BIOMOLECULES (2015)
Innate Host Defense Requires TFEB-Mediated Transcription of Cytoprotective and Antimicrobial Genes
Orane Visvikis et al.
IMMUNITY (2014)
Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease
Victor Tapias et al.
NEUROBIOLOGY OF AGING (2014)
Autophagy in aging and neurodegenerative diseases: implications for pathogenesis and therapy
Chen-Chen Tan et al.
NEUROBIOLOGY OF AGING (2014)
Mitochondrial DNA damage: Molecular marker of vulnerable nigral neurons in Parkinson's disease
Laurie H. Sanders et al.
NEUROBIOLOGY OF DISEASE (2014)
E50K-OPTN-Induced Retinal Cell Death Involves the Rab GTPase-Activating Protein, TBC1D17 Mediated Block in Autophagy
Madhavi Latha Somaraju Chalasani et al.
PLOS ONE (2014)
Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation
Yvette C. Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Mitochondrial DNA Damage as a Peripheral Biomarker for Mitochondrial Toxin Exposure in Rats
Laurie H. Sanders et al.
TOXICOLOGICAL SCIENCES (2014)
Structural basis for phosphorylation-triggered autophagic clearance of Salmonella
Vladimir V. Rogov et al.
BIOCHEMICAL JOURNAL (2013)
Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment
Jason R. Cannon et al.
EXPERIMENTAL NEUROLOGY (2013)
How Parkinsonian Toxins Dysregulate the Autophagy Machinery
Ruben K. Dagda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates
Jelena Korac et al.
JOURNAL OF CELL SCIENCE (2013)
Rotenone Inhibits Autophagic Flux Prior to Inducing Cell Death
Burton J. Mader et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Optineurin immunoreactivity in neuronal nuclear inclusions of polyglutamine diseases (Huntington's, DRPLA, SCA2, SCA3) and intranuclear inclusion body disease
Fumiaki Mori et al.
ACTA NEUROPATHOLOGICA (2012)
Optineurin in Huntington's disease intranuclear inclusions
Claudia Schwab et al.
NEUROSCIENCE LETTERS (2012)
Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
Christina M. Lill et al.
PLOS GENETICS (2012)
Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders
Tibor Hortobagyi et al.
ACTA NEUROPATHOLOGICA (2011)
Rotenone, Paraquat, and Parkinson's Disease
Caroline M. Tanner et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra
Jason R. Cannon et al.
EXPERIMENTAL NEUROLOGY (2011)
Processing of Optineurin in Neuronal Cells
Xiang Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Brainstem and spinal cord motor neuron involvement with optineurin inclusions in proximal-dominant hereditary motor and sensory neuropathy
Koji Fujita et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Localization of MAP1-LC3 in Vulnerable Neurons and Lewy Bodies in Brains of Patients With Dementia With Lewy Bodies
Shinji Higashi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Optineurin in neurodegenerative diseases
Tenshi Osawa et al.
NEUROPATHOLOGY (2011)
Optineurin Is Required for CYLD-Dependent Inhibition of TNFα-Induced NF-κB Activation
Ananthamurthy Nagabhushana et al.
PLOS ONE (2011)
Phosphorylation of the Autophagy Receptor Optineurin Restricts Salmonella Growth
Philipp Wild et al.
SCIENCE (2011)
The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases
Jason R. Cannon et al.
TOXICOLOGICAL SCIENCES (2011)
Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling
Ghanshyam Swarup et al.
JOURNAL OF BIOSCIENCES (2010)
Melatonin Treatment Potentiates Neurodegeneration in a Rat Rotenone Parkinson's Disease Model
Victor Tapias et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Mutations of optineurin in amyotrophic lateral sclerosis
Hirofumi Maruyama et al.
NATURE (2010)
A highly reproducible rotenone model of Parkinson's disease
Jason R. Cannon et al.
NEUROBIOLOGY OF DISEASE (2009)
Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology
Robert E. Drolet et al.
NEUROBIOLOGY OF DISEASE (2009)
Stages in the development of Parkinson's disease-related pathology
H Braak et al.
CELL AND TISSUE RESEARCH (2004)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Recent Knowledge on Molecular Components of Lewy Bodies Discloses Future Therapeutic Strategies in Parkinson's Disease
F. Fornai et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2003)
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
R Betarbet et al.
NATURE NEUROSCIENCE (2000)
In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies
WP Gai et al.
EXPERIMENTAL NEUROLOGY (2000)